Response to "What Is the Optimal Approach to Major ABO-Incompatible Allogeneic Stem Cell Transplantation"

被引:2
作者
Booth, Garrett S.
Gehrie, Eric A.
Savani, Bipin N.
机构
[1] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA
[2] Yale Univ, Dept Lab Med, New Haven, CT USA
[3] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Hematol & Stem Cell Transplantat Sect, Div Hematol Oncol,Med Ctr,Dept Med, Nashville, TN USA
关键词
REDUCTION; ANTIBODY;
D O I
10.1016/j.bbmt.2013.10.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1760 / 1761
页数:2
相关论文
共 5 条
[1]   Clinical Guide to ASO-Incompatible Allogeneic Stem Cell Transplantation [J].
Booth, Garrett S. ;
Gehrie, Eric A. ;
Bolan, Charles D. ;
Savani, Bipin N. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (08) :1152-1158
[2]   Pre-transplant reduction of isohaemagglutinin titres by donor group plasma infusion does not reduce the incidence of pure red cell aplasia in major ABO-mismatched transplants [J].
Damodar, S ;
George, B ;
Mammen, J ;
Mathews, V ;
Srivastava, A ;
Chandy, M .
BONE MARROW TRANSPLANTATION, 2005, 36 (03) :233-235
[3]   A series of surveys on assay for anti-A/B antibody by Japanese ABO-incompatible Transplantation Committee [J].
Kobayashi, T ;
Saito, K .
XENOTRANSPLANTATION, 2006, 13 (02) :136-140
[4]   Comparing the tube and gel techniques for ABO antibody titration, as performed in three European centers [J].
Kumlien, Gunilla ;
Wilpert, Jochen ;
Safwenberg, Jan ;
Tyden, Gunnar .
TRANSPLANTATION, 2007, 84 (12) :S17-S19
[5]   Major ABO-incompatible BMT: isohemagglutinin reduction with plasma exchange is safe and avoids graft manipulation [J].
Sheppard, D. ;
Tay, J. ;
Bryant, A. ;
McDiarmid, S. ;
Huebsch, L. ;
Tokessy, M. ;
Hamelin, L. ;
Saidenberg, E. ;
Bredeson, C. .
BONE MARROW TRANSPLANTATION, 2013, 48 (07) :953-957